Agilent Technologies Denmark ApS has recalled approximately 4,277 units of FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, Ready-to-Use (Dako Omnis). The recall was initiated because the product may produce weak staining, which could lead to false negative identifications of CD20. This laboratory product is used in medical testing to help classify certain types of B-cell tumors. Consumers should contact the manufacturer or their distributor to arrange for a return or replacement.
Weak staining may result in B-cells not being identified correctly, potentially leading to a false negative result. This can cause medical professionals to misclassify tumors, which may delay or alter correct diagnosis and treatment for B-cell related cancers.
Intended for use in immunohistochemistry together with the Dako Omnis instrument.
Intended for use in immunohistochemistry together with the Dako Omnis instrument.
Intended for use in immunohistochemistry together with the Dako Omnis instrument.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.